Repros Therapeutics (RPRX) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $57.16 -0.82%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- RBC cuts Northrop Grumman rating on slower growth, cautious defense outlook
- Rivian reports Q3 2026 production of 19,751 vehicles
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
